ArticleCancers2025
Exosomal Thomsen-Friedenreich Glycoantigen as a Sensitive and Specific Biomarker for Colon, Ovarian and Prostate Cancer Diagnosis.
Yafei Su, Man Qi, Shoaib Vasini, Mary E Reid, Kate Rittenhouse-Olson, Grace K Dy, Yun Wu
Abstract read
In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Yafei SuDepartment of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USA.ORCID 0000-0001-6412-6559 Man QiDepartment of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USA.
Shoaib VasiniDepartment of Electrical Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USA.
Mary E ReidDepartment of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.
Kate Rittenhouse-OlsonFor-Robin, Inc., Buffalo, NY 14221, USA.
Grace K DyDepartment of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.
Yun WuDepartment of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USA.ORCID 0000-0002-6926-777X Funding
Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6MLung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy AssayR01CA272827 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI DY, GRACE, ITO, FUMITO · 2022 to 2025
$3.1MExosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detectionR21CA267934 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI DY, GRACE, RITTENHOUSE-OLSON, KATE W · 2022 to 2023
$428kNCI NIH HHS P30CA016056NCI NIH HHS R01CA272827NCI NIH HHS R21CA267934U.S. National Science Foundation CBET-1337860
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cancer liquid biopsycolon cancerexosomesextracellular vesiclesmulti-cancer detectionovarian cancerprostate cancersurface plasmon resonancethomsen–friedenreich glycoantigen
Identifiers
PMID41374931
PMCPMC12691054
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390